Disclaimer

These recommendations are made according to standards for trustworthy guidelines and targets an international audience with an individual patient perspective. Adaptation to specific countries or contexts should be considered, including the cost-effectiveness of interventions.

Sponsors

The Rapidrecs panel includes clinicians, researchers, methodologists and patient representatives funded by their own institutions, without conflicts of interest and ties with industry. Please see the BMJ RapidRecs publication for details about the RapidRecs panel, their affiliations and declarations of interest. Per O Vandvik, associate professor, Catherine M Otto, professor, Reed A Siemieniuk, methodologist, Rodrigo Bagur, assistant clinical professor, Gordon H Guyatt, distinguished professor,Lyubov Lytvyn, methodologist, Richard Whitlock, associate professor,Trond Vartdal, consultant physician, David Brieger, professor, Bert Aertgeerts, professor, Susanna Price, professor, Farid Foroutan, graduate student, Michael Shapiro, community representative, Ray Mertz, community representative, Frederick A. Spencer, professor

Contact

Per Olav Vandvik

Abstract

The BMJ-RapidRecs project represents a collaboration between MAGIC and The BMJ. In response to potentially practice-changing evidence a guideline panel creates recommendations and all underlying content in MAGICapp, informed by linked systematic reviews. The BMJ publishes the recommendations and systematic reviews in their journals.

Language

no

Population

Pasienter som er eldre enn 85 år med alvorlig symptomatisk aortastenose og lav til middels perioperativ risiko

Outcomes

Population

Pasienter som er mellom 75 og 85 år gamle med alvorlig symptomatisk aortastenose og lav til intermediær perioperativ risiko.

Outcomes

Population

Pasienter som er mellom 65 og 75 år gamle med alvorlig symptomatisk aortastenose og lav til intermediær perioperativ risiko

Outcomes

Population

Pasienter som er mellom 65 år eller yngre med alvorlig symptomatisk aortastenose og lav til intermediær perioperativ risiko

Outcomes

Population

Pasienter med alvorlig symptomatisk aortastenose og lav til intermediær perioperativ risiko som ikke kan gjennomføre transfemoralt, men TAVI eller SAVR

Outcomes